These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 20153263)

  • 1. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.
    Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML
    Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
    Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
    J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.
    Okuda H; Kanai A; Ito S; Matsui H; Yokoyama A
    Nat Commun; 2015 Nov; 6():8869. PubMed ID: 26593443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.
    Benedikt A; Baltruschat S; Scholz B; Bursen A; Arrey TN; Meyer B; Varagnolo L; Müller AM; Karas M; Dingermann T; Marschalek R
    Leukemia; 2011 Jan; 25(1):135-44. PubMed ID: 21030982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
    Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.
    Okuda H; Takahashi S; Takaori-Kondo A; Yokoyama A
    Cell Cycle; 2016 Oct; 15(20):2712-22. PubMed ID: 27564129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.
    Mueller D; Bach C; Zeisig D; Garcia-Cuellar MP; Monroe S; Sreekumar A; Zhou R; Nesvizhskii A; Chinnaiyan A; Hess JL; Slany RK
    Blood; 2007 Dec; 110(13):4445-54. PubMed ID: 17855633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation.
    Yokoyama A
    Front Genet; 2018; 9():722. PubMed ID: 30693017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Yokoyama A
    Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
    Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
    Elife; 2021 Aug; 10():. PubMed ID: 34431785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
    Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
    J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
    Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
    Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.
    Lin C; Smith ER; Takahashi H; Lai KC; Martin-Brown S; Florens L; Washburn MP; Conaway JW; Conaway RC; Shilatifard A
    Mol Cell; 2010 Feb; 37(3):429-37. PubMed ID: 20159561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.
    Bitoun E; Oliver PL; Davies KE
    Hum Mol Genet; 2007 Jan; 16(1):92-106. PubMed ID: 17135274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
    Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
    Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
    Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
    Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.
    Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R
    Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.
    Bizarro S; Cerveira N; Correia C; Lisboa S; Peixoto A; Norton L; Teixeira MR
    Cancer Genet Cytogenet; 2007 Oct; 178(1):61-4. PubMed ID: 17889710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.
    Sobhian B; Laguette N; Yatim A; Nakamura M; Levy Y; Kiernan R; Benkirane M
    Mol Cell; 2010 May; 38(3):439-51. PubMed ID: 20471949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.